2B7K:F:F-iShares MSCI World SRI UCITS ETF EUR (Acc) (EUR)

ETF | Others |

Last Closing

USD 11.484

Change

-0.05 (-0.42)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

+1.60 (+0.28%)

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.45 (-0.86%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.07 (-0.44%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-2.60 (-1.10%)

USD 45.80B
0ZC:F Zscaler Inc

-1.10 (-0.49%)

USD 37.92B
BSND:F Danone SA

-0.20 (-1.37%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-0.46 (-0.36%)

USD 24.77B

ETFs Containing 2B7K:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.75% 33% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.75% 33% F 45% F
Trailing 12 Months  
Capital Gain 6.85% 65% D 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.85% 62% D 56% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.80% 55% F 56% F
Dividend Return 5.80% 52% F 48% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.81% 67% D+ 92% A
Risk Adjusted Return 59.14% 59% D- 71% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike